Aim: To evaluate the correlation of microperimetry (MP) and optical coherence tomography (OCT) in eyes having acute onset of central serous chorioretinopathy (CSCR). Methods: After a detailed ophthalmological examination, all cases were evaluated by fundus fluorescein angiography, OCT and MP. Mean macular thickness was detected by OCT. Mean macular sensitivity (MS) and mean defect (MD) were determined by MP. The correlation between OCT and MP findings was analyzed by Spearman’s correlation test. Results: Fifteen eyes with CSCR of 15 patients with a mean age of 40.5 ± 6.7 years were recruited. The mean visual acuity was 0.7 ± 0.2, and the mean macular thickness was 348.9 ± 75.8 μm. Mean MS and MD were 13.9 ± 4.6 and –5.2 ± 4.1 dB, respectively. The mean macular thickness was significantly correlated with both mean MS and MD (p = 0.011 and p = 0.017, respectively). A significant correlation was also found between mean macualt thickness, MS and MD in the central 1 mm, superior 3 mm and nasal 3 mm of the macula (p < 0.05). Conclusions: Our results demonstrated a significant correlation between structural and functional changes in CSCR. MP provides quantitative measurements of central macular function in CSCR that may supplement OCT findings as well as the better understanding of visual functions during the acute stage of the disease.

Keywords:
Microperimetry, Optical coherence tomography, Central serous chorioretinopathy
1.
Yannuzi LA, Shakin JL, Fisher YL, Altomonte M: Peripheral retinal detachments and retinal pigment epithelial tracts secondary to central serous pigment epitheliopathy. Ophthalmology 1984;91:1554–1572.
2.
Ho I-V, Yannuzzi L: Chronic central serous chorioretinopathy and fundus autofluorescence. Retinal Cases Brief Rep 2008;2:1–5.
3.
Tittl MK, Spaide RF, Wong D, Pilotto E, Yannuzzi LA, Fisher YL, Freund B, Guyer DR, Slakter JS, Sorenson JA: Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999;128:63–68.
4.
Yannuzzi LA: Type-A behaviour and central serous chorioretinopathy. Retina 1987;7:111–130.
5.
Pizzimenti JJ, Daniel KP: Central serous chorioretinopathy after epidural steroid injection. Pharmacotherapy 2005;25:1141–1146.
6.
Folk JC, Thompson HS, Han DP, Brown CK: Visual function abnormalities in central serous retinopathy. Arch Ophthalmol 198;102:1299–1302.
7.
Chuang EL, Sharp DM, Fitzke FW, Kemp CM, Holden AL, Bird AC: Retinal dysfunction in central serous chorioretinopathy. Eye 1987;1:120–125.
8.
Miyake Y, Shiroyama N, Ota I, Horiguchi M: Local macular electroretinographic responses in idiopathic central serous chorioretinopathy. Am J Ophthalmol 1988;106:546–550.
9.
Nagata M, Honda Y: Macular ERG in central serous chorioretinopathy. Jpn J Ophthalmol 1971;15:9–16.
10.
Marmor MF, Tan F: Central serous chorioretinopathy: bilateral multifocal ERG abnormalities. Arch Ophthalmol 1999;117:184–188.
11.
Vajaranant TS, Szlyk JP, Fishman GA, Gieser JP, Seiple W: Localized retinal dysfunction in central serous chorioretinopathy as measured using the multifocal electroretinogram. Ophthalmology 2002;109:1243–1250.
12.
Lai TY, Lai RY, Ngai JW, Chan WM, Li H, Lam DS: First and second-order kernel multifocal electroretinography abnormalities in acute central serous chorioretinopathy. Doc Ophthalmol 2008;116:29–40.
13.
Midena E, Pilotto E, Radin PP, Convento E: Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration: a microperimetry study. Semin Ophthalmol 2004;19:55–61.
14.
Vujosevic S, Midena E, Pilotto E, Radin PP, Chiesa L, Cavarzeran F: Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings. Invest Ophthalmol Vis Sci 2006;47:3044–3051.
15.
Springer C, Volcker HE, Rohrschneider K: Central serous chorioretinopathy – retinal function and morphology: microperimetry and optical coherence tomography. Ophthalmologe 2006;103:791–797.
16.
Jarc-Vidmar M, Popovic P, Hawlina M: Mapping of central visual function by microperimetry and autofluorescence in patients with Best’s vitelliform dystrophy. Eye 2006;20:688–696.
17.
Kiss CG, Barisani-Asenbauer T, Simader C, Maca SM, Schmidt-Erfurth UM: Central visual field impairment during and following cystoid macular edema. Br J Ophthalmol 2008;92:84–88.
18.
Yodoi Y, Tsujikawa A, Kameda T, Otani A, Tamura H, Yoshimura N: Central retinal sensitivity measured with the microperimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2007;143:984–994.
19.
Richter-Mueksch S, Vecsei-Marlovits PV, Scau SG, Kiss CG, Weingessel B, Schmit-Erfurth U: Functional macular mapping in patients with vitreomacular pathologic features before and after surgery. Am J Ophthalmol 2007;144:23–31.
20.
Midena E, Radin PP, Convento EC: Liquid crystal display microperimetry; in Midena E (ed): Perimetry and the Fundus: An Introduction to Microperimetry. Thorofare, Slack Inc, 2007, pp 15–25.
21.
Wang MS, Sander B, Larsen M: Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 2002;133:787–793.
22.
Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A, Manea M: The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 2005;39:87–99.
23.
Eandi CM, Chung JE, Cardillo-Piccolino F, Spaied RF: Optical coherence tomography in unilateral resolved central serous chorioretinopathy. Retina 2005;25:417–421.
24.
Mori F, Ishiko S, Kitaya N, Takamiya A, Sato E, Hikichi T, Yoshida A: Scotoma and fixation patterns using scanning laser ophthalmoscope microperimetry in patients with macular dystrophy. Am J Ophthalmol 2001;132:897–902.
25.
Hikichi T, Ishiko S, Takamiya A, Sato E, Mori F, Takahashi M, Yanagiya N, Akiba J, Yoshida A: Scanning laser ophthalmoscope correlations with biomicroscopic findings and foveal function after macular hole closure. Arch Ophthalmol 2000;118:193–197.
26.
Sjaarda RN, Frank DA, Glaser BM, Thompson JT, Murphy RP: Resolution of an absolute scotoma and improvement of relative scotoma after successful macular hole surgery. Am J Ophthalmol 1993;116:129–139.
27.
Midena E: Microperimetry. Arch Soc Esp Oftalmol 2006;81:183–186.
28.
Toonen F, Remky A, Janssen V, Wolf S, Reim M: Microperimetry in patients with central serous retinopathy. Ger J Ophthalmol 1995;4:331–314.
29.
Okada K, Yamamoto S, Mizunoya S, Hoshino A, Arai M, Takatsuna Y: Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema. Eye 2006;20:805–809.
30.
Carpineto P, Ciancaglini M, Di Antonio L, Gavalas C, Mastropasqua L: Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema. Retina 2007;27:21–29.
31.
Wessing A: Grundsaetzliches zum diagnostischen Fortschritt durch dir Fluoreszenzangiographie. Berl Dtsch Ophthalmol Ges 1973;73:566–568.
32.
Klais CM, Ober MD, Ciardella AP, Yannuzzi LA: Central serous chorioretinopathy; in Ryan SJ, Schachat AP (eds): Retina, ed 4. Philadelphia, Elsevier Mosby, 2006, vol 2, pp 1135–1161.
33.
Chappelow AV, Marmor AF: Multifocal electroretinogram abnormalities persist following resolution of central serous chorioretinopathy. Arch Ophthalmol 2000;118:1211–1215.
34.
Fujii GY, De Juan E Jr, Humayun MS, Sunness JS, Chang TS, Rossi JV: Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol 2003;136:1067–1078.
35.
Einbock W, Moessner A, Schnurrbusch UE, Holz FG, Wolf S, FAM Study Group: Changes in fundus autofluorescence in patients with age-related maculopathy: correlation to visual function: a prospective study. Graefes Arch Clin Exp Ophthalmol 2005;243:300–305.
36.
Bindewald A, Schmitz-Valckenberg S, Jorzikk JJ, Dolar-Szczasny J, Sieber H, Keilhauer C, Weinberger AW, Dithmar S, Pauleikhoff D, Mansmann U, Wolf S, Holz FG: Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration. Br J Ophthalmol 2005;89:874–878.
37.
Lois N, Halfyard AS, Bird AC, Holder GE, Fitzke FW: Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus. Am J Ophthalmol 2004;138:55–63.
38.
Matsumoto H, Kishi S, Otani T, Sato T: Elongation of photoreceptor outer segment in central serous chorioretinopathy. Am J Ophthalmol 2008;145:162–168.
39.
Ojima Y, Tsujikawa A, Hangai M, Nakanishi H, Inoue R, Sakamoto A, Yoshimura N: Retinal sensitivity measured with the Micro Perimeter 1 after resolution of central serous chorioretinopathy. Am J Ophthalmol 2008;146:77–84.
40.
Ozdemir H, Karacorlu SA, Senturk F, Karacorlu M, Uysal O: Assessment of macular function by microperimetry in unilateral resolved central serous chorioretinopathy. Eye 2008;22:204–208.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.